Sunitinib plus paclitaxel in patients with advanced esophageal cancer: A phase II study from the Hoosier Oncology Group.

被引：0
|
作者：
Schmitt, J. M.
Sommers, S. R.
Fisher, W. B.
Ansari, R. H.
Robin, E. L.
Koneru, K.
McClean, J. W.
Liu, Z.
Hanna, N. H.
机构：
[1] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
[2] Univ Hosp Case Med Ctr, Cleveland, OH USA
[3] Med Consultants, Muncie, IN USA
[4] Michiana Hematol Oncol PC, South Bend, IN USA
[5] Community Hosp, Munster, IN USA
[6] Canc Ctr Southern Indiana, Bloomington, IN USA
[7] Med & Surg Specialists LLC, Galesburg, IL USA
[8] Indiana Univ, Div Biostat, Indianapolis, IN 46204 USA
[9] Indiana Univ, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e14661
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14661
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Sunitinib Plus Paclitaxel in Patients with Advanced Esophageal Cancer A Phase II Study from the Hoosier Oncology Group
    Schmitt, Jordan M.
    Sommers, Scott R.
    Fisher, William
    Ansari, Rafat
    Robin, Erwin
    Koneru, Karuna
    McClean, John
    Liu, Ziyue
    Tong, Yan
    Hanna, Nasser
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (04) : 760 - 763
  • [2] Phase II study of gemcitabine plus docetaxel in advanced pancreatic cancer: A Hoosier Oncology Group study
    Schneider, BP
    Ganjoo, KN
    Seitz, DE
    Picus, J
    Fata, F
    Stoner, C
    Calley, C
    Loehrer, PJ
    ONCOLOGY, 2003, 65 (03) : 218 - 223
  • [3] Pemetrexed in patients (pts) with relapsed small cell lung cancer (SCLC): A phase II study from the Hoosier Oncology Group.
    Hanna, N. H.
    Ansari, R.
    Bhatia, S.
    Govindan, R.
    Bruetman, D.
    Hosford, M.
    Fisher, W.
    White, A.
    Breen, T.
    Juliar, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 379S - 379S
  • [4] Carboplatin plus paclitaxel and sequential radiation followed by consolidation carboplatin and paclitaxel in patients with previously untreated locally advanced NSCLC - A Hoosier Oncology Group (HOG) phase II study
    Bhatia, S
    Hanna, N
    Ansari, R
    Einhorn, L
    Sandler, A
    LUNG CANCER, 2002, 38 (01) : 85 - 89
  • [5] Phase II study of paclitaxel and cisplatin in advanced esophageal cancer: A Chinese esophageal cancer group
    Huang, J
    Cai, GR
    Zhang, JM
    Wang, WJ
    Da Chu, T
    Sun, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 356S - 356S
  • [6] Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: A phase II Hoosier Oncology Group Study
    Li, JX
    Juliar, B
    Yiannoutsos, C
    Ansari, R
    Fox, E
    Fisch, MJ
    Einhorn, LH
    Sweeney, CJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) : 1185 - 1191
  • [7] A phase I study of weekly gemcitabine and docetaxel in patients with advanced cancer: A Hoosier Oncology Group study
    Ganjoo, KN
    Gordon, MS
    Sandler, AB
    Warner, RE
    Fife, K
    Poirier, S
    Seshadri, R
    Loehrer, PJ
    ONCOLOGY, 2002, 62 (04) : 299 - 304
  • [8] A phase II study of carboplatin plus gemcitabine in advanced non-small-cell lung cancer (NSCLC) - A hoosier oncology group study
    Ng, EW
    Sandler, AB
    Robinson, L
    Einhorn, LH
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (06): : 550 - 553
  • [9] Gefitinib plus celecoxib in chemotherapy-naive patients with stage IIIB/IV non-small cell lung cancer (NSCLC): A phase II study from the Hoosier Oncology Group.
    Agarwala, A. K.
    Einhorn, L.
    Fisher, W.
    Bruetman, D.
    McClean, J.
    Taber, D.
    Titzer, M.
    Juliar, B.
    Breen, T.
    Hanna, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 380S - 380S
  • [10] Paclitaxel Plus Bevacizumab in Patients with Chemosensitive Relapsed Small Cell Lung Cancer A Safety, Feasibility, and Efficacy Study from the Hoosier Oncology Group
    Jalal, Shadia
    Bedano, Pablo
    Einhorn, Lawrence
    Bhatia, Sumeet
    Ansari, Rafat
    Bechar, Naftali
    Koneru, Karuna
    Govindan, Ramaswamy
    Wu, Jingwei
    Yu, Menggang
    Schneider, Bryan
    Hanna, Nasser
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : 2008 - 2011
12345